Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
about
Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma.T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin
P2860
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@ast
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@en
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@nl
type
label
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@ast
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@en
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@nl
prefLabel
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@ast
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@en
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@nl
P2860
P1433
P1476
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
@en
P2860
P304
P356
10.3109/10428199909167383
P577
1999-01-01T00:00:00Z